Direct comparison of the specialised blood fibrosis tests FibroMeter V2G and Enhanced Liver Fibrosis score in patients with non-alcoholic fatty liver disease from tertiary care centres
The Enhanced Liver Fibrosis score (ELF) and the FibroMeter are two specialized blood fibrosis tests which include direct markers of liver fibrosis. They have been shown to be more accurate than the simple blood fibrosis tests FIB4 and the non-alcoholic fatty liver disease (NAFLD) fibrosis score (NFS...
Gespeichert in:
Veröffentlicht in: | Alimentary Pharmacology & Therapeutics (Suppl) 2019-12, Vol.50 (11-12), p.1214-1222 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The Enhanced Liver Fibrosis score (ELF) and the FibroMeter
are two specialized blood fibrosis tests which include direct markers of liver fibrosis. They have been shown to be more accurate than the simple blood fibrosis tests FIB4 and the non-alcoholic fatty liver disease (NAFLD) fibrosis score (NFS).
To directly compare the accuracies of ELF and FibroMeter
for the non-invasive diagnosis of liver fibrosis in NAFLD.
Four hundred and seventeen patients with biopsy-proven NAFLD were enrolled from two tertiary care centres. Four blood fibrosis tests were calculated: ELF, FibroMeter
, NFS, and FIB4. Advanced fibrosis F3/4 on liver biopsy (NASH CRN scoring) was the primary endpoint.
Areas under the receiver operating characteristic (AUROC) curve for advanced fibrosis were not significantly different between the direct markers of liver fibrosis (hyaluronate, PIIINP, TIMP-1, alpha2-macroglobulin) and the simple blood fibrosis tests NFS and FIB4. ELF (0.793 ± 0.022) and FibroMeter
(0.804 ± 0.021) had significantly higher AUROC than NFS (0.722 ± 0.025, P |
---|---|
ISSN: | 0269-2813 0953-0673 1365-2036 |
DOI: | 10.1111/apt.15529 |